Quote:

---

In the event of a ‘spin-out,’ Amarantus plans to maintain an equity ownership, in order to put a significant, growing equity asset on our balance sheet. We would also enable current shareholders to participate directly in our soon-to-be revenue generating diagnostics business via a stock dividend, while also maintaining an equity position in our therapeutics and discovery business units. We believe this could unlock some of the significant value inherent in our equity by providing a direct return on investment (ROI) to our long-term shareholders who have remained loyal to the company as we have assembled this tremendous portfolio in areas of significant growth potential in the years ahead.

---